Company Overview
Snapshot
Founded in June 2018 by Shachar Paz, Michal Marks, and Assaf Deutsch, NeuroTrigger operates with 1–10 employees. The company has secured $4.12 million across five funding rounds. A significant milestone for NeuroTrigger was receiving FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB) in October 2023.
Business overview
NeuroTrigger develops advanced wearable muscle re-education systems. Their core technology involves a lightweight, rechargeable stimulator paired with a pre-gelled Y-shaped electrode that delivers electrical pulses to elicit muscle contractions. This system is designed to improve muscle performance, increase range of motion, and prevent disuse atrophy across various body parts, including facial musculature. The company also offers a mobile application that communicates with the stimulator via Bluetooth, allowing users, caregivers, or technicians to monitor status and adjust parameters. NeuroTrigger operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and digital health, serving patients and healthcare providers.
Strategic signal
NeuroTrigger's receipt of FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB) in October 2023 is a strong indicator of market readiness and regulatory validation. This clearance is crucial for commercialization in the US market, signaling to investors and innovation teams that the company has overcome a significant hurdle in bringing its medical device to patients and healthcare professionals, potentially accelerating adoption and revenue growth.
Log in to access full profile ›Company Intelligence Q&A
- What is NeuroTrigger's primary product?
- NeuroTrigger develops a wearable muscle re-education system that uses a rechargeable stimulator and pre-gelled electrodes to deliver electrical pulses for muscle contraction, aiming to improve performance and prevent atrophy.
- When was NeuroTrigger founded?
- NeuroTrigger was founded in June 2018.
- What significant regulatory milestone did NeuroTrigger achieve?
- In October 2023, NeuroTrigger received FDA 510(k) clearance for its non-invasive muscle stimulation system (NTB).
- Has NeuroTrigger received any grants?
- In July 2023, NeuroTrigger received a grant from the BIRD Foundation. Previously, in September 2019, the company secured a grant from the Israel Innovation Authority.
- How does NeuroTrigger's system integrate with mobile technology?
- NeuroTrigger's wearable stimulator communicates with a unique mobile phone application via Bluetooth, enabling users, caregivers, or technicians to monitor the stimulator's status and adjust various parameters.